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Introduction
Extracorporeal membrane oxygenation (ECMO) support
has been used for resuscitation since the 1960s, and 
it provides temporary cardiopulmonary support for pa-
tients with diseases that are expected to be reversible1.
There are two modes of ECMO: venoarterial mode,
which provides hemodynamic support, and venovenous
mode, which provides pulmonary support. In the emer-
gency department (ED), ECMO plays an important role
in treating in-hospital cardiac arrest (IHCA) patients, and
improves the overall survival rate to discharge from
13.4–17% to 34.1%2–4. In addition, ECMO-assisted resus-
citation may also extend the acceptable duration of
cardiopulmonary resuscitation (CPR), leading to higher
survival rates, which in turn gives the opportunity to
provide further intervention4. We may predict a better
outcome of survival and weaning rate by evaluating
the central nervous system and renal function in the
first 24 hours after resuscitation, and the duration of
CPR and etiology of cardiac arrest may affect survival4.
Case Report
A 44-year-old female presented with chest pain and cold
sweating for 30 minutes. Two days previously, she had
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SUMMARY
Extracorporeal membrane oxygenation (ECMO) is used as a resuscitative tool for cardiogenic shock or cardiac
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There were no major complications noted during the hospital stay. In conclusion, the use of ECMO to support
cardiopulmonary function during cardiopulmonary resuscitation can improve the chance of survival in cases
of IHCA that have better central nervous function after being weaned from ECMO. Shorter cardiopulmonary
resuscitation duration and less organ damage may predict a better outcome in these patients. [International
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just been discharged from the cardiovascular depart-
ment with a diagnosis of acute myocardial infarction,
a consequence of a triple vessel occlusion. She had
received percutaneous transluminal coronary angio-
plasty at the previous admission, followed by implan-
tation of stents inside the three main coronary arteries.
In addition, she had a 5-year history of hypertension and
hyperlipidemia, without regular medical control.
Initially, the patient visited our ED with clear con-
sciousness. Her vital signs were as follows: body tem-
perature, 36.0°C; pulse rate, 106 beats/min, respiratory
rate, 20 breaths/min, and blood pressure, 83/57 mmHg.
Physical examination revealed tachycardia and tachy-
pnea with clear breath sounds bilaterally. The first elec-
trocardiogram showed ST-segment elevations in leads
V2 to V5 (Figure 1), and the values of cardiac enzymes,
including creatine phosphokinase, creatine kinase MB,
and troponin I, were within the normal range. Twenty-
four minutes after she presented to the ED, the patient
was found to have nausea and vomiting, and became
progressively more drowsy. Unfortunately, pulseless
electrical activity followed, leading to an immediate
start of CPR. During her resuscitation, there were fewer
responses to defibrillation applied during ventricular
tachycardia, which occurred once, and ventricular fibril-
lation, which occurred three times. Spontaneous circu-
lation with hypotension returned, but only persisted for
a few minutes. She was considered for treatment with
ECMO to help restore her cardiopulmonary function,
and ECMO was quickly applied through the femoral ves-
sels for at least 90 minutes after this emergency episode.
Return of spontaneous heart beating was noted a
short time after ECMO support. Primary percutaneous
transluminal coronary angioplasty was then performed,
and revealed diffuse coronary vessel spasm with some
thrombosis in the right coronary artery. No obvious ste-
nosis was found. Repeated electrocardiogram showed
sinus tachycardia and complete right bundle branch
block (Figure 2). The patient was then sent to the
intensive care unit for further care.
In the intensive care unit, an intra-aortic balloon
pump was used to decrease the afterload and increase
the perfusion of the coronary arteries. Inotropic agents
including dopamine and dobutamine were given to
maintain adequate blood pressure. Heparin dosage was
adjusted according to the activated clotting time. A
central venous catheter and Swan-Ganz catheter were
inserted to monitor fluid status, cardiac output and
heart chamber pressure, and thus monitor heart con-
tractile function indirectly. The ECMO flow and speed
settings were regulated according to the arterial blood
gas and blood pressure. Biochemistry was checked daily,
including sodium, potassium, calcium, and cardiac en-
zyme levels. Blood products, such as packed red blood
cells, fresh frozen plasma and platelets, were transfused
as necessary.
Acute pulmonary edema was found during hospital-
ization. We used diuretics to maintain adequate urine
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Figure 1. Initial electrocardiogram: ST-segment elevations in leads V2 to V5.
output and edema control. During the period of ECMO
use, the patient was sedated with midazolam and she
could respond to some questions by blinking her eyes.
A prophylactic antibiotic was used to prevent catheter-
related infection, and a blood culture showed no bac-
terial growth. Her electrocardiogram showed severely
impaired left ventricle systolic performance, diastolic
compliance, and regional wall motion abnormality, and
her renal function progressively worsened (creatine,
1.9–3.0 mg/dL). During this hospital stay, there were
no severe ECMO-related complications found, includ-
ing hemorrhage, thromboembolism or vessel injuries.
Unfortunately, ECMO was refused by the patient’s fam-
ily and removed on the 12th day for financial reasons,
after which the patient died.
Discussion
ECMO during CPR improved the outcome for patients
who had a cardiac arrest or shock when it was used 
in an emergency5,6, especially for the main causes of
cardiac arrest, including acute coronary infarction, pul-
monary embolism, and cardiomyopathy7. ECMO can
provide immediate cardiopulmonary function support
to preserve tissue perfusion and to decrease myocar-
dial loading8. The use of ECMO during CPR in the ED re-
quires specialized equipment and well-trained surgeons,
physicians, nurses and therapists, who are available
24 hours a day. This is also an expensive and invasive
procedure, so the criteria for ECMO use varies widely
from institution to institution. Exclusion criteria in most
studies are age above 75 years, severe irreversible brain
damage, malignancy, and uncontrolled infection or
coagulopathy4,8,9. According to the 2005 American Heart
Association Guidelines for Cardiopulmonary Resusci-
tation and Emergency Cardiovascular Care, ECMO during
CPR should be performed for IHCA patients who have
reversible underlying diseases or have an opportunity
for further intervention such as heart transplant7,10.
IHCA carries a high risk of mortality and morbidity
in the ED. In conventional CPR for cardiac arrest patients,
the outcome worsens if the duration of resuscitation is
longer than 10 minutes11–13. One study revealed that
ECMO during CPR was beneficial for short-term and
long-term survival of patients with IHCA of cardiac ori-
gin, who received conventional CPR for more than 10
minutes9. The study also identified that the duration
of CPR and etiology of cardiac arrest may influence
survival9. Acute coronary syndrome and obstructive
lesions had both poor weaning and survival rates9. The
organ damage after arrest in the first 24 hours may
predict the outcome, and organ dysfunction scores of
renal and central nervous function were used for eval-
uation8,9. Previous studies have presented some bio-
chemical findings to predict the outcome during ECMO
support. Creatine kinase, creatine kinase MB, aspar-
tate aminotransferase, lactate acid, and renal function
International Journal of Gerontology | June 2010 | Vol 4 | No 2 101
■ ■ECMO-assisted Resuscitation
I
II
III
II
Loc 10025 25 mm/sec 10.0 mm/mV F ∼ W 0.50–40
aVR V1
V2
V3 V6
V5aVL
aVF
V4
Figure 2. Repeated electrocardiogram after extracorporeal membrane oxygenation and percutaneous transluminal coronary
angioplasty: sinus tachycardia and complete right bundle branch block.
during ECMO support were predictive of weaning and
survival8. Some studies had discussed the correlation
with initial rhythm, defibrillation and outcome4. They
reported that the most common initial rhythm was
pulseless ventricular tachycardia or ventricular fibrilla-
tion4,9, and most of the patients with these rhythms
were defibrillated. These patients may have lower mor-
tality than those showing asystole or pulseless electrical
activity as their initial rhythm9.
Some studies mentioned that ECMO support may ex-
tend the duration of CPR, and that the average duration
was around 55.7 minutes4,8. The successful weaning rate
was 58.4% and the survival-to-discharge rate was 34.1%4.
If the CPR duration was longer than 1 hour, the wean-
ing rate and survival rate decreased markedly4,9. In
addition, the CPR duration was shorter in survivors
(average duration, 43.2 minutes) than in non-survivors
(average duration, 62.1 minutes)4,8,14.
More than half of the patients received subsequent
interventions, such as coronary angioplasty, surgery or
transplantation4. The correlation of subsequent inter-
ventions with survival is still controversial because of
a lack of evidence4,8. In addition, it is noted that the
duration of CPR is correlated with neurologic dys-
function4,8,14. Compared with survivors who received
conventional CPR, most survivors who received ECMO
support had good cerebral performance category sta-
tus at hospital discharge, even if they received pro-
longed CPR9.
In the ED, ECMO support for out-of-hospital cardiac
arrest patients is still controversial because of the uncer-
tain time of arrest. The survival-to-discharge rate is
low, and the patients have poor cerebral performance
category status9. In contrast, one recent case report
showed a successful outcome when ECMO was applied
to a 37-year-old out-of-hospital cardiac arrest male who
received prolonged CPR, and he was discharged with-
out neurologic complications15. During his resuscitation,
he had refractory ventricular fibrillation and did not re-
gain spontaneous circulation after treatment with CPR,
defibrillation or medication15. The patient received
ECMO support after CPR for 2 hours in total, and he
then received primary percutaneous transluminal coro-
nary angioplasty with intravascular stent insertion for
his totally occluded left anterior descending coronary
artery15. Therefore, ECMO may be helpful for those pa-
tients, whose cardiac rhythms are restored transiently
but not successfully maintained because of recurrent
ventricular fibrillation. The timing of ECMO use for
out-of-hospital cardiac arrest patients should be dis-
cussed in further studies15.
In conclusion, ECMO during CPR may provide a better
outcome for IHCA patients if ECMO is available within an
acceptable duration (at least 60 minutes) after arrest. The
CPR duration and organ damage have a great impact
on survival, so we should try to shorten the duration
between decision-making and ECMO application. Well-
trained practitioners and equipment from different
departments should be integrated, and the patient selec-
tion criteria should be clearly established for ECMO use.
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